Kiniksa Pharmaceuticals to Present at Evercore ISI 4th Annual HealthCONx Conference

Rhea-AI Summary

Kiniksa Pharmaceuticals (Nasdaq: KNSA) will participate in a fireside chat at the Evercore ISI 4th Annual HealthCONx Conference on November 30, 2021, at 12:10 p.m. ET. The presentation will be available via live webcast on Kiniksa’s website, with a replay accessible approximately 48 hours post-event. Kiniksa is focused on developing therapeutic medicines for patients with significant unmet medical needs, boasting a portfolio including ARCALYST®, mavrilimumab, vixarelimab, and KPL-404, targeting various immunological conditions.

HAMILTON, Bermuda, Nov. 23, 2021 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) announced today that management will participate in a fireside chat at the Evercore ISI 4^th Annual HealthCONx Conference on Tuesday, November 30, 2021 at 12:10 p.m. Eastern Time.

A live webcast of Kiniksa’s presentation will be accessible through the Investors & Media section of the company’s website at www.kiniksa.com. A replay of the webcast will also be available on Kiniksa’s website within approximately 48 hours after the event.

About Kiniksa
Kiniksa is a biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Kiniksa’s portfolio of assets, ARCALYST^® (rilonacept), mavrilimumab, vixarelimab and KPL-404, are based on strong biologic rationale or validated mechanisms, target underserved conditions, and offer the potential for differentiation. These assets are designed to modulate immunological pathways across a spectrum of diseases. For more information, please visit www.kiniksa.com.

ARCALYST^® is a registered trademark of Regeneron Pharmaceuticals, Inc.

Every Second Counts! ® Kiniksa Investor and Media Contact Rachel Frank (339) 970-9437 rfrank@kiniksa.com

FAQ

What event is Kiniksa Pharmaceuticals participating in on November 30, 2021?

Kiniksa Pharmaceuticals will participate in a fireside chat at the Evercore ISI 4th Annual HealthCONx Conference.

What time does Kiniksa's presentation start at the HealthCONx Conference?

Kiniksa's presentation starts at 12:10 p.m. Eastern Time on November 30, 2021.

Where can I watch Kiniksa's presentation?

The presentation will be available via live webcast on Kiniksa’s website.

Will there be a replay of Kiniksa's presentation at the HealthCONx Conference?

Yes, a replay of the webcast will be available on Kiniksa's website approximately 48 hours after the event.

What therapeutic areas does Kiniksa Pharmaceuticals focus on?

Kiniksa focuses on developing therapeutic medicines for debilitating diseases with significant unmet medical needs.